RMT
Royce Micro-Cap Trust, Inc.
$13.74
-0.02
(-0.15%)
Mkt Cap
741.75M
Volume
84,501
52W Range
9.13-14.78
Sector
Financial Services
Beta
1.21
EPS (TTM)
1.66
P/E Ratio
8.36
Revenue (TTM)
44.12M
Rev Growth (5Y)
+59.6%
EPS Growth (5Y)
-10.3%
AlphaVal · Fair Value
What we estimate one share is worth
$34.68
Undervalued
strong signal
60.0% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B
Banks, Insurers & Asset Managers
74.3 / 100 composite
A bank, insurer or asset manager — graded A–F vs. similar companies.
Company Description
Royce Micro-Cap Trust, Inc. is a closed-ended equity mutual fund launched and managed Royce & Associates, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value stocks of companies with market capitalization of less than $500 million. The fund benchmarks the performance of its portfolios against Russell 2000 Index. Royce Micro-Cap Trust, Inc was formed on December 14, 1993 and is domiciled in the United States.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44.12M | 6.41M | 8.26M | 21.06M | 96.30M | 4.26M | 75.43M | (46.47M) | 61.54M | 5.12M | 5.52M | 4.57M |
| Net Income | 87.76M | 65.94M | 72.89M | (102.76M) | 95.26M | 125.16M | 74.63M | (47.15M) | 60.92M | 64.36M | (48.77M) | 8.22M |
| EPS | 1.66 | 1.30 | 1.49 | -2.15 | 2.16 | 2.86 | 1.78 | -1.17 | 1.58 | 1.70 | -1.34 | 0.24 |
| Free Cash Flow | (2.89M) | 3.17M | 27.36M | 32.68M | 20.87M | 13.99M | 15.39M | 40.26M | 456,006 | 13.01M | 41.36M | 38.84M |
| FCF / Share | -0.05 | 0.06 | 0.56 | 0.69 | 0.47 | 0.32 | 0.37 | 1.00 | 0.01 | 0.34 | 1.14 | 1.14 |
| Operating CF | (2.89M) | 3.17M | 27.36M | 32.68M | 20.87M | 13.99M | 15.39M | 40.26M | 456,006 | 13.01M | 41.36M | 38.84M |
| Total Assets | 651.74M | 569.54M | 523.86M | 500.61M | 613.78M | 538.80M | 427.50M | 367.96M | 455.55M | 409.25M | 359.16M | 448.64M |
| Total Debt | 20.00M | 2.00M | 2.00M | 11.00M | 22.00M | 22.00M | 22.00M | 22.00M | 45.00M | 45.00M | 45.00M | 60.00M |
| Cash & Equiv | 38,529 | 37,945 | 95,396 | 28,064 | 14,568 | 9,662 | 67,624 | 425 | 0 | 639 | 50,124 | 186 |
| Book Value | 630.80M | 566.78M | 520.49M | 465.89M | 590.31M | 515.92M | 404.81M | 345.50M | 409.90M | 363.70M | 312.41M | 387.49M |
| Return on Equity | 0.14 | 0.12 | 0.14 | -0.22 | 0.16 | 0.24 | 0.18 | -0.14 | 0.15 | 0.18 | -0.16 | 0.02 |
| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 | Q4 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.02M | 2.39M | 28.36M | 39.98M | 4.23M | 4.03M | 3.85M | 3.65M | 6.64M | 2.21M | 2.08M | 2.18M |
| Net Income | 88.41M | (659,046) | 42.25M | 23.69M | 44.00M | 28.89M | 39.37M | (142.13M) | (12.14M) | 107.40M | 154.26M | (29.10M) |
| EPS | 1.67 | -0.01 | 0.82 | 0.47 | 0.87 | 0.60 | 0.82 | -3.08 | -0.26 | 2.42 | 3.47 | -0.68 |
| Free Cash Flow | (2.02M) | (7.18M) | 115,020 | 8.69M | 131,500 | (919,289) | (677,203) | (407,904) | 2.93M | (940,826) | (954,309) | (232,692) |
| FCF / Share | -0.04 | -0.14 | 0.00 | 0.17 | 0.00 | -0.01 | -0.01 | -0.00 | 0.03 | -0.01 | -0.02 | -0.01 |
| Operating CF | (2.02M) | (7.18M) | 115,019 | 8.69M | 131,500 | (919,289) | (677,203) | (407,904) | 2.93M | (940,826) | (954,309) | (232,692) |
| Total Assets | 651.74M | 577.00M | 569.54M | 538.75M | 523.86M | 509.33M | 500.61M | 67.76M | 613.78M | 637.45M | 538.80M | 391.81M |
| Total Debt | 20.00M | 20.00M | 2.00M | 2.00M | 2.00M | 22.00M | 11.00M | 4.00M | 22.00M | 22.00M | 22.00M | 22.00M |
| Cash & Equiv | 38,529 | 72,583 | 37,945 | 22,695 | 95,396 | 45,751 | 28,064 | 4,177 | 14,568 | 7,607 | 9,662 | 826 |
| Book Value | 630.80M | 555.33M | 566.78M | 535.43M | 520.49M | 486.16M | 465.89M | 63.60M | 590.31M | 614.64M | 515.92M | 368.76M |
| Return on Equity | 0.14 | -0.00 | 0.07 | 0.04 | 0.08 | 0.06 | 0.08 | -2.23 | -0.02 | 0.17 | 0.30 | -0.08 |
RMT News
Royce Micro-Cap Trust (NYSE: RMT) as of Jun 30, 2026
RMT: Micro-Caps Are On Fire! Collect Income From The Growth
RMT: Micro Caps With A 6% Yield, 12% Discount
Royce Micro-Cap Trust (NYSE: RMT) as of May 31, 2026
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.21 Per Share
Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.21 Per Share
Royce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026
Royce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026
Resolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026